Issue 4, 2017

Targeted drug delivery using iRGD peptide for solid cancer treatment

Abstract

Many solid tumor types, such as pancreatic cancer, have a generally poor prognosis, in part because the delivery of a therapeutic regimen is prohibited by pathological abnormalities that block access to tumor vasculature, leading to poor bioavailability. The recent development of the tumor-penetrating iRGD peptide that is covalently conjugated on the nanocarriers' surface or co-administered with nanocarriers becomes a popular approach for tumor targeting. More importantly, scientists have unlocked an important tumor transcytosis mechanism by which drug-carrying nanoparticles directly access solid tumors (that seems to be independent to leaky vasculature), thereby allowing systemically injected nanocarriers to more abundantly distribute at the tumor site with improved efficacy. In this focused review, we summarize the design and implementation strategy for iRGD-mediated tumor targeting. This includes the working principle of such a peptide and discussion on a patient-specific iRGD effect in vivo, commensurate with the level of key biomarker (i.e. neuropilin-1) expression in tumor vasculature. This highlights the necessity to contemplate the use of a personalized approach when iRGD technology is used in the clinic.

Graphical abstract: Targeted drug delivery using iRGD peptide for solid cancer treatment

Article information

Article type
Review Article
Submitted
05 juil. 2017
Accepted
16 août 2017
First published
16 août 2017

Mol. Syst. Des. Eng., 2017,2, 370-379

Targeted drug delivery using iRGD peptide for solid cancer treatment

X. Liu, J. Jiang, Y. Ji, J. Lu, R. Chan and H. Meng, Mol. Syst. Des. Eng., 2017, 2, 370 DOI: 10.1039/C7ME00050B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements